New York covid-19 pneumonia vaccine New York

Pfizer begins testing COVID-19 booster shot with pneumococcal vaccine in older adults

Reading now: 808
www.fox29.com

NEW YORK - Pfizer has started testing a booster shot of its COVID-19 vaccine in combination with a pneumococcal vaccine candidate, the company announced this week.

The company has enrolled 600 fully vaccinated adults age 65 or older for the trial, which aims to analyze the safety of when both vaccines are co-administered and the immune responses produced by each shot.The participants will have received their second dose of the Pfizer-BioNTech vaccine at least six months prior to entering the combination study.

Individuals in the study will receive either the company’s 20-valent pneumococcal conjugate vaccine candidate (20vPnC) plus a third dose of the Pfizer-BioNTech COVID-19 vaccine — referred to as a "booster" — or they’ll get the 20vPnC.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA